The significance of TG2-expressing cancer cells in the early-recurrence HCC group should be further investigated by focusing on the communication between HCC and the TME, as well as on the signaling pathways that change due to cancer–stromal interactions, such as the Wnt/β-catenin signaling and TGF-β signaling pathways. Here, TGM2 is linked to cancer.